These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 28966053)

  • 41. Profiling of age-related changes in the tibialis anterior muscle proteome of the mdx mouse model of dystrophinopathy.
    Carberry S; Zweyer M; Swandulla D; Ohlendieck K
    J Biomed Biotechnol; 2012; 2012():691641. PubMed ID: 23093855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated GLUT4 and glycogenin protein abundance correspond to increased glycogen content in the soleus muscle of mdx mice with no benefit associated with taurine supplementation.
    Barker RG; Frankish BP; Xu H; Murphy RM
    Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29484837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice.
    Wineinger MA; Abresch RT; Walsh SA; Carter GT
    Am J Phys Med Rehabil; 1998; 77(1):20-7. PubMed ID: 9482375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of PDE5 inhibition on dystrophic muscle following an acute bout of downhill running and endurance training.
    Batra A; Vohra RS; Chrzanowski SM; Hammers DW; Lott DJ; Vandenborne K; Walter GA; Forbes SC
    J Appl Physiol (1985); 2019 Jun; 126(6):1737-1745. PubMed ID: 30946638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin.
    Holland A; Dowling P; Zweyer M; Swandulla D; Henry M; Clynes M; Ohlendieck K
    Proteomics; 2013 Aug; 13(15):2312-23. PubMed ID: 23713012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
    Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
    Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A single 30 min treadmill exercise session is suitable for 'proof-of concept studies' in adult mdx mice: a comparison of the early consequences of two different treadmill protocols.
    Radley-Crabb H; Terrill J; Shavlakadze T; Tonkin J; Arthur P; Grounds M
    Neuromuscul Disord; 2012 Feb; 22(2):170-82. PubMed ID: 21835619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dystrophinopathy-associated dysfunction of Krebs cycle metabolism.
    Lindsay A; Chamberlain CM; Witthuhn BA; Lowe DA; Ervasti JM
    Hum Mol Genet; 2019 Mar; 28(6):942-951. PubMed ID: 30476171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficits.
    Heier CR; Guerron AD; Korotcov A; Lin S; Gordish-Dressman H; Fricke S; Sze RW; Hoffman EP; Wang P; Nagaraju K
    PLoS One; 2014; 9(11):e112477. PubMed ID: 25390038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential expression of the skeletal muscle proteome in mdx mice at different ages.
    Ge Y; Molloy MP; Chamberlain JS; Andrews PC
    Electrophoresis; 2004 Aug; 25(15):2576-85. PubMed ID: 15300778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.
    Miglietta D; De Palma C; Sciorati C; Vergani B; Pisa V; Villa A; Ongini E; Clementi E
    Orphanet J Rare Dis; 2015 Aug; 10():101. PubMed ID: 26296873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of genes involved in the calcium homeostasis in masticatory muscles of MDX mice.
    Kunert-Keil CH; Gredes T; Lucke S; Botzenhart U; Dominiak M; Gedrange T
    J Physiol Pharmacol; 2014 Apr; 65(2):317-24. PubMed ID: 24781740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypochlorous acid exposure impairs skeletal muscle function and Ca
    Lea TA; Panizza PM; Arthur PG; Bakker AJ; Pinniger GJ
    J Physiol; 2023 Dec; 601(23):5257-5275. PubMed ID: 37864413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.
    Gardan-Salmon D; Dixon JM; Lonergan SM; Selsby JT
    Eur J Appl Physiol; 2011 Nov; 111(11):2763-73. PubMed ID: 21409400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle.
    Abmayr S; Crawford RW; Chamberlain JS
    Hum Mol Genet; 2004 Jan; 13(2):213-21. PubMed ID: 14645204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.
    Villalta SA; Nguyen HX; Deng B; Gotoh T; Tidball JG
    Hum Mol Genet; 2009 Feb; 18(3):482-96. PubMed ID: 18996917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Muscle ERRγ mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming.
    Matsakas A; Yadav V; Lorca S; Narkar V
    FASEB J; 2013 Oct; 27(10):4004-16. PubMed ID: 23781095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophy.
    Carberry S; Zweyer M; Swandulla D; Ohlendieck K
    Int J Mol Med; 2012 Aug; 30(2):229-34. PubMed ID: 22614334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of Dystrophic
    Addinsall AB; Forgan LG; McRae NL; Kelly RW; McDonald PL; McNeill B; McCulloch DR; Stupka N
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32156081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
    Morales MG; Cabrera D; Céspedes C; Vio CP; Vazquez Y; Brandan E; Cabello-Verrugio C
    Cell Tissue Res; 2013 Jul; 353(1):173-87. PubMed ID: 23673415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.